RIPK3 and neoplasm: Notably, the effects of GADD45β are in line with emerging models of sublethal necroptosis, in which partial activation of RIPK3 promotes sustained NF-κB signaling, whereas its complete activation toward full necroptosis leading to a more immunogenic tumor environment [23, 24].